SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16410812
Source:
http://linkedlifedata.com/resource/pubmed/id/16410812
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0035647
,
umls-concept:C0079189
,
umls-concept:C0220825
,
umls-concept:C0441889
,
umls-concept:C0543467
,
umls-concept:C1274040
,
umls-concept:C1527178
,
umls-concept:C1705938
pubmed:issue
3
pubmed:dateCreated
2007-3-1
pubmed:abstractText
To ascertain whether vitreous and plasma levels of vascular endothelial growth factor (VEGF), interleukin-6 (IL-6) and fundus findings could predict the outcome of vitreous surgery in patients with proliferative diabetic retinopathy (PDR).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8703986
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6
,
http://linkedlifedata.com/resource/pubmed/chemical/VEGFA protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0950-222X
pubmed:author
pubmed-author:FunatsuHH
,
pubmed-author:HoriSS
,
pubmed-author:MimuraTT
,
pubmed-author:NakamuraSS
,
pubmed-author:NomaHH
,
pubmed-author:YamashitaHH
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
377-82
pubmed:dateRevised
2009-11-3
pubmed:meshHeading
pubmed-meshheading:16410812-Adult
,
pubmed-meshheading:16410812-Aged
,
pubmed-meshheading:16410812-Diabetic Retinopathy
,
pubmed-meshheading:16410812-Female
,
pubmed-meshheading:16410812-Humans
,
pubmed-meshheading:16410812-Interleukin-6
,
pubmed-meshheading:16410812-Male
,
pubmed-meshheading:16410812-Middle Aged
,
pubmed-meshheading:16410812-Retinal Detachment
,
pubmed-meshheading:16410812-Retinal Neovascularization
,
pubmed-meshheading:16410812-Risk Assessment
,
pubmed-meshheading:16410812-Severity of Illness Index
,
pubmed-meshheading:16410812-Treatment Outcome
,
pubmed-meshheading:16410812-Vascular Endothelial Growth Factor A
,
pubmed-meshheading:16410812-Visual Acuity
,
pubmed-meshheading:16410812-Vitrectomy
,
pubmed-meshheading:16410812-Vitreous Body
,
pubmed-meshheading:16410812-Vitreous Hemorrhage
pubmed:year
2007
pubmed:articleTitle
Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines.
pubmed:affiliation
Department of Ophthalmology, Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan. tfunatsu@ nifty.com
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't